Lucid Diagnostics has submitted its complete clinical evidence package to Medicare’s Molecular Diagnostics Program (MolDX), seeking reconsideration of a Local…
Browsing: Clinical Updates
The American Gastroenterological Association (AGA) has released updated guidelines for managing moderate-to-severe ulcerative colitis (UC), emphasizing advanced pharmacological therapies and…
Multi-cancer early detection (MCED) tests represent a transformative breakthrough in cancer diagnostics, using blood samples to identify biomarkers like circulating…
Dr. David Johnson shared key highlights from the 2024 American College of Gastroenterology (ACG) Annual Scientific Meeting, including promising research…
The American Gastroenterological Association (AGA) recently reviewed endoscopic scoring systems used to evaluate the severity of inflammation and mucosal healing…
In managing Crohn’s disease (CD), diet plays a significant role in symptom management and potentially impacts disease progression. Dr. Berkeley…
Colorectal cancer (CRC) remains a leading cause of cancer-related deaths, with several screening recommendations to enhance early detection. Despite differing…
The FDA has updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic, Wegovy),…
A recent study from the University of Pennsylvania indicates that GLP-1 receptor agonists, commonly used for weight loss and diabetes…
Gastroesophageal reflux disease (GERD) affects an estimated 1.03 billion people worldwide, with prevalence ranging significantly by region. Defined as a…